img

Global Buspirone Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Buspirone Market Research Report 2024

Buspirone, sold under the brand name Buspar among others, is a medication primarily used to treat anxiety disorders, particularly generalized anxiety disorder. Benefits support its short term use. It has not been found to be effective in treating psychosis. It is taken by mouth, and it may take up to four weeks for an effect.
According to Mr Accuracy reports’s new survey, global Buspirone market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Buspirone market research.
Key manufacturers engaged in the Buspirone industry include Bristol Myers Squibb, Apotex, Dr. Reddy's Laboratories, Laboratoires Servier, Teva, AMAG Pharmaceuticals, Mylan, Novartis and Watson Laboratories, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Buspirone were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Buspirone market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Buspirone market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Bristol Myers Squibb
Apotex
Dr. Reddy's Laboratories
Laboratoires Servier
Teva
AMAG Pharmaceuticals
Mylan
Novartis
Watson Laboratories
Hikma
Wockhardt
Cadila Healthcare
Orion Corporation
Segment by Type
5mg
10mg
15mg
30mg

Segment by Application


Hospital
Drug Store

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Buspirone report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Buspirone Market Overview
1.1 Product Overview and Scope of Buspirone
1.2 Buspirone Segment by Type
1.2.1 Global Buspirone Market Value Comparison by Type (2024-2034)
1.2.2 5mg
1.2.3 10mg
1.2.4 15mg
1.2.5 30mg
1.3 Buspirone Segment by Application
1.3.1 Global Buspirone Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Buspirone Market Size Estimates and Forecasts
1.4.1 Global Buspirone Revenue 2018-2034
1.4.2 Global Buspirone Sales 2018-2034
1.4.3 Global Buspirone Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Buspirone Market Competition by Manufacturers
2.1 Global Buspirone Sales Market Share by Manufacturers (2018-2024)
2.2 Global Buspirone Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Buspirone Average Price by Manufacturers (2018-2024)
2.4 Global Buspirone Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Buspirone, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Buspirone, Product Type & Application
2.7 Buspirone Market Competitive Situation and Trends
2.7.1 Buspirone Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Buspirone Players Market Share by Revenue
2.7.3 Global Buspirone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Buspirone Retrospective Market Scenario by Region
3.1 Global Buspirone Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Buspirone Global Buspirone Sales by Region: 2018-2034
3.2.1 Global Buspirone Sales by Region: 2018-2024
3.2.2 Global Buspirone Sales by Region: 2024-2034
3.3 Global Buspirone Global Buspirone Revenue by Region: 2018-2034
3.3.1 Global Buspirone Revenue by Region: 2018-2024
3.3.2 Global Buspirone Revenue by Region: 2024-2034
3.4 North America Buspirone Market Facts & Figures by Country
3.4.1 North America Buspirone Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Buspirone Sales by Country (2018-2034)
3.4.3 North America Buspirone Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Buspirone Market Facts & Figures by Country
3.5.1 Europe Buspirone Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Buspirone Sales by Country (2018-2034)
3.5.3 Europe Buspirone Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Buspirone Market Facts & Figures by Country
3.6.1 Asia Pacific Buspirone Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Buspirone Sales by Country (2018-2034)
3.6.3 Asia Pacific Buspirone Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Buspirone Market Facts & Figures by Country
3.7.1 Latin America Buspirone Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Buspirone Sales by Country (2018-2034)
3.7.3 Latin America Buspirone Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Buspirone Market Facts & Figures by Country
3.8.1 Middle East and Africa Buspirone Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Buspirone Sales by Country (2018-2034)
3.8.3 Middle East and Africa Buspirone Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Buspirone Sales by Type (2018-2034)
4.1.1 Global Buspirone Sales by Type (2018-2024)
4.1.2 Global Buspirone Sales by Type (2024-2034)
4.1.3 Global Buspirone Sales Market Share by Type (2018-2034)
4.2 Global Buspirone Revenue by Type (2018-2034)
4.2.1 Global Buspirone Revenue by Type (2018-2024)
4.2.2 Global Buspirone Revenue by Type (2024-2034)
4.2.3 Global Buspirone Revenue Market Share by Type (2018-2034)
4.3 Global Buspirone Price by Type (2018-2034)
5 Segment by Application
5.1 Global Buspirone Sales by Application (2018-2034)
5.1.1 Global Buspirone Sales by Application (2018-2024)
5.1.2 Global Buspirone Sales by Application (2024-2034)
5.1.3 Global Buspirone Sales Market Share by Application (2018-2034)
5.2 Global Buspirone Revenue by Application (2018-2034)
5.2.1 Global Buspirone Revenue by Application (2018-2024)
5.2.2 Global Buspirone Revenue by Application (2024-2034)
5.2.3 Global Buspirone Revenue Market Share by Application (2018-2034)
5.3 Global Buspirone Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Bristol Myers Squibb
6.1.1 Bristol Myers Squibb Corporation Information
6.1.2 Bristol Myers Squibb Description and Business Overview
6.1.3 Bristol Myers Squibb Buspirone Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Bristol Myers Squibb Buspirone Product Portfolio
6.1.5 Bristol Myers Squibb Recent Developments/Updates
6.2 Apotex
6.2.1 Apotex Corporation Information
6.2.2 Apotex Description and Business Overview
6.2.3 Apotex Buspirone Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Apotex Buspirone Product Portfolio
6.2.5 Apotex Recent Developments/Updates
6.3 Dr. Reddy's Laboratories
6.3.1 Dr. Reddy's Laboratories Corporation Information
6.3.2 Dr. Reddy's Laboratories Description and Business Overview
6.3.3 Dr. Reddy's Laboratories Buspirone Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Dr. Reddy's Laboratories Buspirone Product Portfolio
6.3.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.4 Laboratoires Servier
6.4.1 Laboratoires Servier Corporation Information
6.4.2 Laboratoires Servier Description and Business Overview
6.4.3 Laboratoires Servier Buspirone Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Laboratoires Servier Buspirone Product Portfolio
6.4.5 Laboratoires Servier Recent Developments/Updates
6.5 Teva
6.5.1 Teva Corporation Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva Buspirone Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Teva Buspirone Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 AMAG Pharmaceuticals
6.6.1 AMAG Pharmaceuticals Corporation Information
6.6.2 AMAG Pharmaceuticals Description and Business Overview
6.6.3 AMAG Pharmaceuticals Buspirone Sales, Revenue and Gross Margin (2018-2024)
6.6.4 AMAG Pharmaceuticals Buspirone Product Portfolio
6.6.5 AMAG Pharmaceuticals Recent Developments/Updates
6.7 Mylan
6.6.1 Mylan Corporation Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Buspirone Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Mylan Buspirone Product Portfolio
6.7.5 Mylan Recent Developments/Updates
6.8 Novartis
6.8.1 Novartis Corporation Information
6.8.2 Novartis Description and Business Overview
6.8.3 Novartis Buspirone Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Novartis Buspirone Product Portfolio
6.8.5 Novartis Recent Developments/Updates
6.9 Watson Laboratories
6.9.1 Watson Laboratories Corporation Information
6.9.2 Watson Laboratories Description and Business Overview
6.9.3 Watson Laboratories Buspirone Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Watson Laboratories Buspirone Product Portfolio
6.9.5 Watson Laboratories Recent Developments/Updates
6.10 Hikma
6.10.1 Hikma Corporation Information
6.10.2 Hikma Description and Business Overview
6.10.3 Hikma Buspirone Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Hikma Buspirone Product Portfolio
6.10.5 Hikma Recent Developments/Updates
6.11 Wockhardt
6.11.1 Wockhardt Corporation Information
6.11.2 Wockhardt Buspirone Description and Business Overview
6.11.3 Wockhardt Buspirone Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Wockhardt Buspirone Product Portfolio
6.11.5 Wockhardt Recent Developments/Updates
6.12 Cadila Healthcare
6.12.1 Cadila Healthcare Corporation Information
6.12.2 Cadila Healthcare Buspirone Description and Business Overview
6.12.3 Cadila Healthcare Buspirone Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Cadila Healthcare Buspirone Product Portfolio
6.12.5 Cadila Healthcare Recent Developments/Updates
6.13 Orion Corporation
6.13.1 Orion Corporation Corporation Information
6.13.2 Orion Corporation Buspirone Description and Business Overview
6.13.3 Orion Corporation Buspirone Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Orion Corporation Buspirone Product Portfolio
6.13.5 Orion Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Buspirone Industry Chain Analysis
7.2 Buspirone Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Buspirone Production Mode & Process
7.4 Buspirone Sales and Marketing
7.4.1 Buspirone Sales Channels
7.4.2 Buspirone Distributors
7.5 Buspirone Customers
8 Buspirone Market Dynamics
8.1 Buspirone Industry Trends
8.2 Buspirone Market Drivers
8.3 Buspirone Market Challenges
8.4 Buspirone Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Buspirone Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Buspirone Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Buspirone Market Competitive Situation by Manufacturers in 2022
Table 4. Global Buspirone Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Buspirone Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Buspirone Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Buspirone Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Buspirone Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Buspirone, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Buspirone, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Buspirone, Product Type & Application
Table 12. Global Key Manufacturers of Buspirone, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Buspirone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Buspirone as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Buspirone Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Buspirone Sales by Region (2018-2024) & (K Units)
Table 18. Global Buspirone Sales Market Share by Region (2018-2024)
Table 19. Global Buspirone Sales by Region (2024-2034) & (K Units)
Table 20. Global Buspirone Sales Market Share by Region (2024-2034)
Table 21. Global Buspirone Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Buspirone Revenue Market Share by Region (2018-2024)
Table 23. Global Buspirone Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Buspirone Revenue Market Share by Region (2024-2034)
Table 25. North America Buspirone Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Buspirone Sales by Country (2018-2024) & (K Units)
Table 27. North America Buspirone Sales by Country (2024-2034) & (K Units)
Table 28. North America Buspirone Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Buspirone Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Buspirone Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Buspirone Sales by Country (2018-2024) & (K Units)
Table 32. Europe Buspirone Sales by Country (2024-2034) & (K Units)
Table 33. Europe Buspirone Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Buspirone Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Buspirone Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Buspirone Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Buspirone Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Buspirone Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Buspirone Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Buspirone Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Buspirone Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Buspirone Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Buspirone Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Buspirone Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Buspirone Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Buspirone Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Buspirone Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Buspirone Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Buspirone Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Buspirone Sales (K Units) by Type (2018-2024)
Table 51. Global Buspirone Sales (K Units) by Type (2024-2034)
Table 52. Global Buspirone Sales Market Share by Type (2018-2024)
Table 53. Global Buspirone Sales Market Share by Type (2024-2034)
Table 54. Global Buspirone Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Buspirone Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Buspirone Revenue Market Share by Type (2018-2024)
Table 57. Global Buspirone Revenue Market Share by Type (2024-2034)
Table 58. Global Buspirone Price (US$/Unit) by Type (2018-2024)
Table 59. Global Buspirone Price (US$/Unit) by Type (2024-2034)
Table 60. Global Buspirone Sales (K Units) by Application (2018-2024)
Table 61. Global Buspirone Sales (K Units) by Application (2024-2034)
Table 62. Global Buspirone Sales Market Share by Application (2018-2024)
Table 63. Global Buspirone Sales Market Share by Application (2024-2034)
Table 64. Global Buspirone Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Buspirone Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Buspirone Revenue Market Share by Application (2018-2024)
Table 67. Global Buspirone Revenue Market Share by Application (2024-2034)
Table 68. Global Buspirone Price (US$/Unit) by Application (2018-2024)
Table 69. Global Buspirone Price (US$/Unit) by Application (2024-2034)
Table 70. Bristol Myers Squibb Corporation Information
Table 71. Bristol Myers Squibb Description and Business Overview
Table 72. Bristol Myers Squibb Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Bristol Myers Squibb Buspirone Product
Table 74. Bristol Myers Squibb Recent Developments/Updates
Table 75. Apotex Corporation Information
Table 76. Apotex Description and Business Overview
Table 77. Apotex Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Apotex Buspirone Product
Table 79. Apotex Recent Developments/Updates
Table 80. Dr. Reddy's Laboratories Corporation Information
Table 81. Dr. Reddy's Laboratories Description and Business Overview
Table 82. Dr. Reddy's Laboratories Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Dr. Reddy's Laboratories Buspirone Product
Table 84. Dr. Reddy's Laboratories Recent Developments/Updates
Table 85. Laboratoires Servier Corporation Information
Table 86. Laboratoires Servier Description and Business Overview
Table 87. Laboratoires Servier Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Laboratoires Servier Buspirone Product
Table 89. Laboratoires Servier Recent Developments/Updates
Table 90. Teva Corporation Information
Table 91. Teva Description and Business Overview
Table 92. Teva Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Teva Buspirone Product
Table 94. Teva Recent Developments/Updates
Table 95. AMAG Pharmaceuticals Corporation Information
Table 96. AMAG Pharmaceuticals Description and Business Overview
Table 97. AMAG Pharmaceuticals Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. AMAG Pharmaceuticals Buspirone Product
Table 99. AMAG Pharmaceuticals Recent Developments/Updates
Table 100. Mylan Corporation Information
Table 101. Mylan Description and Business Overview
Table 102. Mylan Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Mylan Buspirone Product
Table 104. Mylan Recent Developments/Updates
Table 105. Novartis Corporation Information
Table 106. Novartis Description and Business Overview
Table 107. Novartis Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Novartis Buspirone Product
Table 109. Novartis Recent Developments/Updates
Table 110. Watson Laboratories Corporation Information
Table 111. Watson Laboratories Description and Business Overview
Table 112. Watson Laboratories Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Watson Laboratories Buspirone Product
Table 114. Watson Laboratories Recent Developments/Updates
Table 115. Hikma Corporation Information
Table 116. Hikma Description and Business Overview
Table 117. Hikma Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Hikma Buspirone Product
Table 119. Hikma Recent Developments/Updates
Table 120. Wockhardt Corporation Information
Table 121. Wockhardt Description and Business Overview
Table 122. Wockhardt Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Wockhardt Buspirone Product
Table 124. Wockhardt Recent Developments/Updates
Table 125. Cadila Healthcare Corporation Information
Table 126. Cadila Healthcare Description and Business Overview
Table 127. Cadila Healthcare Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Cadila Healthcare Buspirone Product
Table 129. Cadila Healthcare Recent Developments/Updates
Table 130. Orion Corporation Corporation Information
Table 131. Orion Corporation Description and Business Overview
Table 132. Orion Corporation Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Orion Corporation Buspirone Product
Table 134. Orion Corporation Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Buspirone Distributors List
Table 138. Buspirone Customers List
Table 139. Buspirone Market Trends
Table 140. Buspirone Market Drivers
Table 141. Buspirone Market Challenges
Table 142. Buspirone Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Buspirone
Figure 2. Global Buspirone Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Buspirone Market Share by Type in 2022 & 2034
Figure 4. 5mg Product Picture
Figure 5. 10mg Product Picture
Figure 6. 15mg Product Picture
Figure 7. 30mg Product Picture
Figure 8. Global Buspirone Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Buspirone Market Share by Application in 2022 & 2034
Figure 10. Hospital
Figure 11. Drug Store
Figure 12. Global Buspirone Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 13. Global Buspirone Market Size (2018-2034) & (US$ Million)
Figure 14. Global Buspirone Sales (2018-2034) & (K Units)
Figure 15. Global Buspirone Average Price (US$/Unit) & (2018-2034)
Figure 16. Buspirone Report Years Considered
Figure 17. Buspirone Sales Share by Manufacturers in 2022
Figure 18. Global Buspirone Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Buspirone Players: Market Share by Revenue in 2022
Figure 20. Buspirone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Buspirone Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 22. North America Buspirone Sales Market Share by Country (2018-2034)
Figure 23. North America Buspirone Revenue Market Share by Country (2018-2034)
Figure 24. United States Buspirone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Canada Buspirone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 26. Europe Buspirone Sales Market Share by Country (2018-2034)
Figure 27. Europe Buspirone Revenue Market Share by Country (2018-2034)
Figure 28. Germany Buspirone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. France Buspirone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. U.K. Buspirone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Italy Buspirone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Russia Buspirone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Asia Pacific Buspirone Sales Market Share by Region (2018-2034)
Figure 34. Asia Pacific Buspirone Revenue Market Share by Region (2018-2034)
Figure 35. China Buspirone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. Japan Buspirone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. South Korea Buspirone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. India Buspirone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Australia Buspirone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. China Taiwan Buspirone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Indonesia Buspirone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Thailand Buspirone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Malaysia Buspirone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Latin America Buspirone Sales Market Share by Country (2018-2034)
Figure 45. Latin America Buspirone Revenue Market Share by Country (2018-2034)
Figure 46. Mexico Buspirone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Brazil Buspirone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Argentina Buspirone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Middle East & Africa Buspirone Sales Market Share by Country (2018-2034)
Figure 50. Middle East & Africa Buspirone Revenue Market Share by Country (2018-2034)
Figure 51. Turkey Buspirone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Saudi Arabia Buspirone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. UAE Buspirone Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Global Sales Market Share of Buspirone by Type (2018-2034)
Figure 55. Global Revenue Market Share of Buspirone by Type (2018-2034)
Figure 56. Global Buspirone Price (US$/Unit) by Type (2018-2034)
Figure 57. Global Sales Market Share of Buspirone by Application (2018-2034)
Figure 58. Global Revenue Market Share of Buspirone by Application (2018-2034)
Figure 59. Global Buspirone Price (US$/Unit) by Application (2018-2034)
Figure 60. Buspirone Value Chain
Figure 61. Buspirone Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed